Actively Recruiting
Evaluation of Image Quality of Investigational R1 and HighRes OCT Devices Compared to SPECTRALIS in Adults With Normal and Diseased Eyes
Led by Heidelberg Engineering GmbH · Updated on 2026-08-26
97
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing the image quality of two investigational devices, R1 and HighRes OCT, with the approved SPECTRALIS device in adults who have either normal eyes or various retinal diseases such as age-related macular degeneration and diabetic retinopathy. The study aims to evaluate how well these devices capture detailed images and key anatomical structures in the eye. Participants will undergo imaging using different modalities including autofluorescence imaging with blue and green light, multicolor imaging, infrared reflectance imaging, OCT imaging with volume and line scans, and OCT angiography with volume and SCOUT scans. Each participant will be imaged with all three devices following a randomized crossover design. During the study, participants will have multiple imaging sessions to assess image quality and visibility of eye structures. Safety monitoring will occur from enrollment until study completion, expected about one year after starting. The main outcomes measured include grading of image quality and visibility of anatomical features six months after image acquisition. Participants will be involved in following test procedures and providing consent, with careful monitoring for any safety concerns throughout the study.
CONDITIONS
Brief Title
High Resolution Imaging OCT Study
Research Team
A
Aike T. Schweda, PhD
C
Clinical Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here